In a significant push towards deep-tech healthcare innovation, the Technology Development Board (TDB), under the Department of Science & Technology, has signed an agreement with Ayukriyam Innovations Pvt. Ltd. to support the development of “Autoscope” – a fully automated Whole Slide Imaging and AI-driven diagnostic system.
Ayukriyam Innovations is a deep-tech spin-off from the Molecular Imaging & Diagnostics Lab at Indian Institute of Technology Delhi. The company focuses on advancing healthcare diagnostics through AI-integrated microscopy systems designed to deliver rapid and accurate detection of infectious diseases, especially in resource-constrained settings.
The Autoscope platform is being developed as an automated whole slide imaging system integrated with artificial intelligence for diagnostic analysis. It aims to bridge critical gaps in pathology infrastructure by enabling high-throughput, standardized, and scalable diagnostic workflows. Built on indigenous research and development, the system is expected to reduce reliance on imported high-end imaging equipment while improving diagnostic precision.
TDB’s financial support will facilitate the establishment of a dedicated manufacturing facility, production of multiple batches, and comprehensive field evaluations. The initiative is expected to accelerate commercialization of the technology and strengthen India’s diagnostic ecosystem by making advanced healthcare solutions more affordable and accessible.
Rajesh Kumar Pathak, Secretary, TDB, emphasized that indigenous development of AI-enabled diagnostic platforms is essential for enhancing India’s healthcare infrastructure and reducing import dependence. He noted that the support aligns with the vision of promoting self-reliance in medical technology.
Promoters of Ayukriyam Innovations expressed gratitude for the assistance, stating that it would significantly fast-track manufacturing readiness and field deployment of the Autoscope system across the country.
The project reflects TDB’s continued commitment to funding commercialization of homegrown technologies and fostering innovation-led growth in critical sectors such as healthcare and medical devices.



